Follow-up studies of hepatitis C association with an intravenous immunoglobulin.
Yu
M W
MW
Division of Hematology, CBER/FDA, Bethesda, MD, USA.
D004340:Drug Contamination; D005500:Follow-Up Studies; D006526:Hepatitis C / Q000635:transmission*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects*
D016756:Immunoglobulins, Intravenous